Background. Testosteroneincreasesleanmassandmayhelptocounterthechangesinmusclearchitectureassociated withsarcopenia.Thisstudywasdesignedtoinvestigatetheeffectsoftestosteronereplacementtherapyonskeletalmuscle architectureinintermediate-frailandfrailelderlymen.
T ESTOSTERONE (T) may increase skeletal muscle volumebypromotinghypertrophyofmyofibers (1) . T appears to cause similar effects in younger and older men (2) ,highlightingthatskeletalmuscleretainsahigh degreeofplasticityevenintoolderage.Tlevelsinmen begintodecreasebyapproximately1%peryearafterthe fourthdecadeoflife(3)inparallelwiththereductionin skeletal muscle mass and strength (4) . This waning of anabolicmaintenancemaybeonefactorimplicatedinthe atrophy of skeletal muscle with old age (sarcopenia). T replacement therapy may therefore delay or minimize age-related muscle atrophy, thus providing the rationale forTtherapyincombatingtheeffectsofsarcopeniaand frailty (5) . Changesinmusclesizeandstructurecanbedetectedby usingultrasoundtoassessthegeometricarrangementofits fibers, termed muscle architecture (6) . Muscle thickness (MT; Figure 1 ) is a simple index of lean body mass (of BriefReport EffectsofTestosteroneonSkeletalMuscleArchitecture inIntermediate-FrailandFrailElderlyMen whichskeletalmuscleisthelargestsinglecomponent (7)) andisdefinedasthedistancebetweenthedeepandsuperficialaponeuroses (8) .Fasciclelength(L f ),measuredasthe distance between the insertions of the fascicle into the deep and superficial aponeuroses (8) , is proportional to thenumberofsarcomeresarrangedinseriesandtheexcursionrangeofthemusclefiber(9)(Figure1).Pennation angle (q, the angle of fascicular insertion into the deep aponeurosisofthemuscle(8))isproportionaltothenumber ofsarcomerespackedinparallelalongtheaponeurosisand iscloselyrelatedtotheforce-generatingcapacityofthe muscle(Figure1).L f andqarereducedinaging(9)andare typical features of sarcopenia (9) . However, changes in musclearchitectureinrelationtovariationsinTarelargely unknown. Assessmentofskeletalmuscleusingultrasonographyhas beenvalidatedbycomparisonwithdirectanatomicalmeasurementoncadavericspecimens (8) .Thishasbeenshown tobeasensitivetoolforassessingchangesinmusclestructureandsize(forreview,see (10) ).However,thereislittle evidenceontheuseofultrasoundtoinvestigatechangesin skeletalmusclearchitectureinresponsetoandrogenadministration,particularlywhengivenasphysiologicaldosesin oldermen.
Hence,theaimofthisstudywastoinvestigatetheeffects of T replacement on muscle architecture in intermediatefrailandfrail (11) elderlymenwithlowtoborderline-low Tlevelsusingultrasonography.
Materials and Methods

Design
This was a single-center, randomized, double-blind placebo-controlledtrial.
Participants
Thisinvestigationwasasubstudyofalargerclinicaltrial (12) .Participantswerecommunity-dwellingmenaged≥65 years with one or more of Fried's frailty criteria (11) and morning(before11.00am)totalT≤12nmol/L(345ng/dL) orcalculatedfreeT≤250pmol/L(7.2ng/dL).Amongthe 272menrandomizedintothemainstudy(12),30intermedi-ate-frail and frail men (mean age 72.6 ± 5.7 years) were enrolled and underwent ultrasound assessments of the gastrocnemiusmedialis(GM)muscle.ThesubstudywasapprovedbytheCentralManchesterResearchEthicsCommitteeasasubstantialamendmenttothemainstudy(reference number03/CM/632) (12) .Separatewritteninformedconsent forthissubstudywasobtainedfromeachparticipant.
Intervention
Men in the active group received transdermal T gel (Testogel1%;BayerScheringPharma,Berlin,Germany)at adoseof50mg/dayfor6months,andthoseinthecontrol groupreceivedamatchedplacebogel.Thedoseofthegel wasadjustedto75or25mg/dayaccordingtoserumTat Day10and3months.DoseadjustmentwasundertakenifT levels remained outside the target range (18-30 nmol/L); theplacebogroupthereforereceivedthemaximum"dose," anddoubleblindingwaspreserved.
Analysis of Blood Samples
T and sex hormone-binding globulin levels were measured by chemiluminescent immunoassay (Roche Elecsys E170 platform, Roche Diagnostics GmBH, Mannheim, Germany) at baseline, Day 10, 3 months, and 6 months. Inter-andintra-assaycoefficientofvariationforTwas1.1% and3.7%,respectively,andsexhormone-bindingglobulin 1.7%and3.2%,respectively.FreeTwascalculatedusing the Vermeulen equation (13) . Safety monitoring was performedasdescribedinthemainstudy (12) .
Analysis of Muscle Architecture by Ultrasound
MT,L f ,andq(asdescribedearlier)ofthedominantGM muscleineachparticipantwereassessedatbaselineandat theendoftreatment(6-monthtimepoint).Theparticipant layproneonanexaminationbed,withthefeetpositioned overtheendofthebedatanangleof~90°totheshin.A water-solubletransmissiongelwasplacedovertheheadof the probe to increase acoustic coupling. The head of the probewasheldagainsttheskinsurfacetoprovideanimage ofboththesuperficialandthedeepaponeurosesofGMand of a number of clearly visible fascicles ( Figure 1 ). Static ultrasound images (Koninklijke Philips Electronics N.V., Amsterdam,TheNetherlands)wereobtainedalongthemidsagittallineoftheGMmuscle,midwaybetweentheproximalanddistaltendoninsertionsofthemuscle.Imageswere recordedonvideohomesystem(VHS)andlaterdigitized foranalysisusingimage-processingsoftware(ImageJ;U.S. National Institutes of Health, Bethesda, MD). Care was takentoaligntheultrasoundprobewiththeorientation oftheGMfasciclesandtoexertminimalpressuretothe probetoavoidcompressionoftheunderlyingmuscle.All measurements were made in triplicate on one scan and measuredagainonthesamerecordedimageonaseparate day by the same observer (R.A.A.). The mean of thesesixvalueswasusedforanalysis.
Statistical Analysis
Astherewerenopreviousdataonwhichtobaseaformal power calculation, 30 participants were selected and consecutivelyenrolledintothisexploratorysubstudy.Thetrial blindingmeantthatitwasnotpossibletoguaranteeequal numbersinthetwotreatmentarms.
All participants providing baseline and 6-month data wereincludedintheanalysis.Followingthemaintrialanalysis plan, an analysis of covariance model adjusting for baselinefrailtystatus(1or>1frailtycriteria)wasusedto assesstheeffectofTtreatment(comparedwithplacebo)on GM muscle architecture. A simpler covariate adjustment schemewasspecifiedhereduetothesmallersamplesize and the fact that the participants in this substudy were recruitedoverarelativelyshorttimeperiod.Pairedttests were used to compare changes in T over time. Analyses wereperformedinStata(StataCorp,CollegeStation,TX). Significancewassetatp≤.05.
Repeatability and Reliability of Muscle Measurements by Ultrasound
TodeterminerepeatabilityofthemeasurementofMT,L f , andq,twomeasurementsweretakenoneachoftwoseparate scansfor10differentparticipants.Estimatesoftypicalerror, intra-classcorrelationcoefficients,andconfidenceintervals werecalculated.
Results
Ofthe30participantsenrolled,16participantsreceivedT gel and 14 received placebo gel. One participant failed to attendatbaselinescanandoneat6months,giving28 participants (15 T and 13 placebo) in the main analyses. Participant characteristics were well balanced across the two groups at baseline (Table 1) as were the ultrasound parameters(Table3).Dataforthemeasurementofmuscle architectural parameters showed low typical error values andhighintra-classcorrelationcoefficients(Table2).
Effects of Treatment on Serum T Levels
Mean(±SD)totalTincreasedfrom11.6±3.5to18.0± 8.1nmol/LintheT-treatedgroupafter10days(p=.002) and was maintained throughout the 6-month treatment period.Similarly,mean(±SD)freeTincreasedfrom176± 37to326±125pmol/L(p<.001).Nosubstantivechanges wereseenintheplacebogroup(totalT:10.4±3.4-10.5± 3.8nmol/LandfreeT:171-47to174±60pmol/L).
Effects on Muscle Architecture Assessed by Ultrasound
TheresultsofthestudyforGMmusclearchitecturearepresentedinTable3.Therewasasignificanteffectoftreatment Although it should be emphasized that magnetic resonance imaging or computed tomography remain the most accuratewayofcalculatingwholemusclevolume,previous studiesemployingtheultrasoundmethodtoassessmuscle size (8, 16) have shown the technique to be accurate and cost-effective in detecting hypertrophy or atrophy and is therefore of benefit when magnetic resonance imaging or computed tomography are not available. Furthermore, ultrasound-basedmusclesizemeasurementshavebeenshown to be highly correlated with magnetic resonance imaging (17) anddualenergyx-rayabsorptiometry (7)inquantifyingleanbodymass.Theinclusionofdataonmusclefascicle geometrymaythusaffordclinicians'moreinsightintothe degreeofchangeinmusclemassratherthanrelyingonMT astheonlymarkerofmusclesize.
There is only one other study that used ultrasound to investigate architectural changes in response to androgen administration,butthiswascoupledwithheavyresistance exercise in a group of previously strength-trained young men and involved intramuscular injection of supraphysiological doses of testosterone enanthate (TE) (18) . In this small study, there was a significant increase in triceps brachiiMTinbothgroups,whichtendedtobegreaterin theTEgroup(n=5)whencomparedwiththenon-TEgroup (n = 4; 29.5% increase vs 13.8% increase, respectively): though this interaction was not statistically significant. L f wasnotshowntochangesignificantlyovertimeinresponse tothetrainingorTE (18) .However,qincreasedtoagreater degree in the androgen-treated group, (18) indicating that thetrainingregimecausedsubstantialincreasesincontractile tissue, which were potentiated by supraphysiological dosesofTE.Althoughthissmallstudyfailedtodemonstrate atreatmenteffectforMT (18) ,thetrendoftheresponse doescorroborateourpresentresults.
Insummary,althoughthepresentstudydoesnotprovide evidence of hypertrophy of GM following T therapy, it showsthatMTwasclearlyimprovedintheT-treatedgroup, withoutsignificantreorganizationofthefasciculararrangement. This study contributes to the understanding of the changesinmusclearchitectureinducedbyTandisconsistent with the findings of previous reports which showed androgens to be effective in maintaining lean body mass (12, (19) (20) (21) .Thisinvestigationalsoaddstothelistofstudies thathavefoundultrasoundtobeausefulmethodofassessing musclesizeandarchitecture (9, 15, 16, 18, 22) .Duetoitsnoninvasive nature, minimal training, mobility, and economy, muscle ultrasonography offers many advantages in clinical practice.Futurestudiesinvolvinglargersamplesizes,longer treatment duration, and incorporation of resistance training mayelucidatetherelationshipbetweenT,musclearchitecture, musclestrength,andfrailtyinelderlymen. 
Discussion
The present results demonstrate that increasingT for 6 monthsleadstopreservationofMTcomparedwithplacebo. Toourknowledge,thisisthefirstclinicalstudytoshowa significanteffectofandrogensonmusclearchitectureusing ultrasonographyinintermediate-frailandfrailelderlymen. Althoughtherewasnosignificanteffectoftreatmenton L f or q, the results of this exploratory investigation are encouragingastheyindicatethatTtherapywasbeneficial inmaintainingmusclesizebyamelioratingthedecreasein MT associated with aging and low T. Typically, marked hypertrophyofapennateskeletalmusclewouldbeaccompaniedbyanincreaseinq (14) .However,smallchangesin musclesizesuchasthoseencounteredinthisstudyareunlikelytoleadtomodificationsinq.Therefore,Ttreatment inthisstudyprobablyamelioratedthedeteriorationinmusclearchitecturebutdidnotcausehypertrophy.Thissuggests that the accumulation of new contractile tissue along the aponeurosiswasnotsufficienttoleadtogeometricalchanges inthearrangementofmusclefibersbutwaseffectiveinpreventingalossofmusclemassbyretainingMT.Previously, anage-associateddecreaseinL f hasbeendemonstrated(9), whereaschangesinL f withhypertrophyarenormallyassociatedwithresistance-trainingregimesinvolvingeccentric contractions, which cause muscle stretch (15) . Thus, it is notsurprisingthatabsoluteL f didnotincreaseinresponse toT treatment alone.Although L f tended to decline less rapidly in the T group over the course of this study, the treatmenteffectdidnotreachsignificance. 
